Document:

Exhibit 4.4

 

 

THE INTERPUBLIC GROUP OF COMPANIES, INC.

and

SUNTRUST BANK

Trustee

__________________________

Third Supplemental Indenture

Dated as of March 28, 2005

to the Senior Debt Indenture dated as of November 12, 2004

as amended and supplemented by the Second Supplemental Indenture dated as of November 18, 2004

____________________________

 

 

 

 

	
             
 	
             
 	
             
 
	
             
 	
             
 	
             
 

 

 

 

 

THIRD SUPPLEMENTAL INDENTURE, dated as of 9:00 p.m. March 28, 2005 (the “Effective Time”), between THE INTERPUBLIC GROUP OF COMPANIES, INC., a Delaware corporation (the “Company”) and SUNTRUST BANK, a Georgia banking corporation, as trustee (the “Trustee”).

RECITALS OF THE COMPANY

WHEREAS, the Company has duly issued 6.25% Senior Unsecured Notes due 2014 in the aggregate principal amount of $350,000,000 (the “2014 Securities”) pursuant to an Indenture dated as of November 12, 2004, between the Company and the Trustee (the “Senior Debt Indenture”), as amended and supplemented by the second supplemental indenture dated as of November 18, 2004 (together, the “Indenture”), and the 2014 Securities are outstanding on the date hereof;

WHEREAS, the Company has received the written consent from Holders (as defined in the Indenture) of a majority in aggregate principal amount of the outstanding 2014 Securities to certain amendments to the Indenture upon the terms and subject to the conditions set forth in the Company’s Consent Solicitation Statement dated March 18, 2005 and the accompanying Consent Form;

WHEREAS, Section 9.02 of the Senior Debt Indenture provides that, with the consent of the Holders of a majority in aggregate principal amount of the outstanding 2014 Securities, the Company and the Trustee may enter into an indenture supplemental to the Indenture for the purpose of amending, modifying or changing the Indenture or the 2014 Securities;

WHEREAS, the Board of Directors of Company has by resolution dated March 17, 2005 authorized the execution and delivery of this third supplemental indenture dated March 28, 2005 (the “Supplemental Indenture”);

WHEREAS, Section 9.04 of the Indenture provides that a supplemental indenture becomes effective in accordance with its terms and thereafter binds every Holder;

NOW, THEREFORE, the parties hereto agree as follows:

ARTICLE 1

DEFINITIONS AND OTHER PROVISIONS OF GENERAL APPLICATION

SECTION 1.01.  Effective Time. This Supplemental Indenture with respect to the2014 Securities is effective as of the Effective Time.

SECTION 1.02.  Provisions of the Indenture .Except insofar as herein otherwise expressly provided, all the definitions, provisions, terms and conditions of the Indenture shall remain in full force and effect. The Indenture, as amended and supplemented by this Supplemental Indenture, is in all respects ratified and confirmed, and the Indenture and this Supplemental Indenture shall be read, taken and considered as one and the same instrument for all purposes and every Holder of 2014 Securities authenticated and delivered under the Indenture shall be bound hereby.

 

 

 

	
             
 	
             
 	
             
 
	
             
 	
            1
 	
             
 

 

 

 

 

SECTION 1.03.  Definitions.  For all purposes of the Indenture relating to the 2014 Securities amended hereby, except as otherwise expressly provided or unless the subject matter or context otherwise requires:

(1)           any reference to an “Article” or a “Section” refers to an Article or Section, as the case may be, of this Supplemental Indenture;

(2)           the terms defined in Article 2 have the meanings assigned to them in that Article and include the plural as well as the singular;

(3)           each capitalized term that is used in this Supplemental Indenture but not defined herein shall have the meaning specified in the Indenture;

(4)           all other terms used herein which are defined in the Trust Indenture Act, either directly or by reference therein, or defined by the rules of the Securities and Exchange Commission and not otherwise defined herein, have the meanings assigned to them therein;

(5)           all accounting terms not otherwise defined herein have the meanings assigned to them in accordance with GAAP;

(6)           the word “including” (and with correlative meaning “include”) means including, without limiting the generality of, any description preceding such term; and

(7)           the words “herein,” “hereof” and “hereunder” and other words of similar import refer to the Indenture as a whole and not to any particular Article, Section or other subdivision.

ARTICLE 2  

AMENDMENT TO ARTICLE 1 OF THE INDENTURE

Section 1.01 of the Indenture with respect to the 2014 Securities is hereby amended by inserting the following terms:

“Additional Consent Fee” means with respect to the 2014 Securities $1.25 for each $1,000 in principal amount of the 2014 Securities as to which the Company has received and accepted consents to the Amendments, as may be payable to holders of record as of March 9, 2005 in accordance with the Solicitation Documents.

“Amendments” means with respect to the 2014 Securities the amendments to Section 5.01 set forth in Article 3 of the third supplemental indenture dated as of March 28, 2005.

“Covenant Reversion Date” means, with respect to the 2014 Securities, the earliest of 5:30 p.m., New York City time, on (i) the Business Day following the Company’s failure to pay the Initial Consent Fee, if due, for the 2014 Securities in accordance with the Solicitation Documents, (ii) the Business Day following the Company’s failure to pay the Additional Consent Fee, if due, for the 2014 Securities in accordance with the Solicitation Documents and (iii) September 30, 2005.

 

 

	
             
 	
             
 	
             
 
	
             
 	
            2
 	
             
 

 

 

 

 

“Initial Consent Fee” means with respect to the 2014 Securities $2.50 for each $1,000 in principal amount of the 2014 Securities as to which the Company has received and accepted consents to the Amendments, as may be payable to holders of record as of March 9, 2005 in accordance with the Solicitation Documents.

“SEC Reports” means the Company’s Annual Report on Form 10-K for the year ended December 31, 2004 and Quarterly Reports on Form 10-Q for the three months ended March 31, 2005 and June 30, 2005, respectively, and other information, documents and reports which the Company may be required to file with the Commission pursuant to Section 13 or 15(d) of the Exchange Act.

“Solicitation Documents” means the Consent Solicitation Statement dated as of March 18, 2005 and the related Consent Form, each as may be amended and supplemented from time to time.

“2014 Securities” means the 6.25% Senior Unsecured Notes due 2014.

ARTICLE 3

AMENDMENT TO SECTION 5.01 OF THE INDENTURE

Section 5.01 of the Indenture with respect to the 2014 Securities is hereby amended by inserting the following sentence at the end of the last paragraph of such Section:

“Notwithstanding any of the foregoing, the failure of the Company to comply with Section 7.04(1) of this Indenture or §314 of the Trust Indenture Act during the period beginning on April 1, 2005 and ending at 5:30 p.m., New York City time on the Covenant Reversion Date shall not constitute a Default with respect to the 2014 Securities under clause (4) above; provided, however, that any foregoing failure to comply with Section 7.04(1) of this Indenture or §314 of the Trust Indenture Act shall constitute a Default as of the Covenant Reversion Date for the 2014 Securities if, as of 5:30 p.m., New York City time on the Covenant Reversion Date, the Company shall have failed to file the SEC Reports with the SEC in a form that causes the Company to be current in all material respects in its filing obligations under the Exchange Act.”

ARTICLE 4

MISCELLANEOUS

SECTION 4.01.  Integral Part.  This Supplemental Indenture constitutes an integral part of the Indenture with respect to the 2014 Securities only.

SECTION 4.02.  Adoption, Ratification and Confirmation.  The Indenture, as supplemented and amended by this Supplemental Indenture with respect to the 2014 Securities, is in all respects hereby adopted, ratified and confirmed, and this Supplemental Indenture shall be deemed part of the Indenture in the manner and to the extent herein and therein provided.  The provisions of this Supplemental Indenture shall, subject to the terms hereof, supersede the provisions of the Indenture to the extent the Indenture is inconsistent herewith.

 

 

	
             
 	
             
 	
             
 
	
             
 	
            3
 	
             
 

 

 

 

 

SECTION 4.03.  Counterparts.  This Supplemental Indenture may be executed in any number of counterparts, each of which so executed shall be deemed to be an original, but all such counterparts shall together constitute but one and the same instrument.

SECTION 4.04.  Governing Law.  THE INDENTURE SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 

SECTION 4.05.  Conflict of Any Provision of Indenture with Trust Indenture Act.  If and to the extent that any provision of the Indenture limits, qualifies or conflicts with a provision required under the terms of the Trust Indenture Act, the Trust Indenture Act provision shall control.

SECTION 4.06.  Effect of Headings.  The Article and Section headings herein are for convenience only and shall not affect the construction hereof.

SECTION 4.07.  Severability of Provisions.  In case any provision in the Indenture or in the 2014 Securities shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby.

SECTION 4.08.  Successors and Assigns.  All covenants and agreements in the Indenture by the parties hereto shall bind their respective successors and assigns and inure to the benefit of their respective successors and assigns, whether so expressed or not.

SECTION 4.09.  Benefit of Indenture.  Nothing in this Supplemental Indenture, express or implied, shall give to any Person, other than the parties hereto, any Security Registrar, any Paying Agent, and their successors hereunder, and the Holders of the 2014 Securities, any benefit or any legal or equitable right, remedy or claim hereunder or under the Indenture.

SECTION 4.10.  Acceptance by Trustee.  The Trustee accepts the amendments to the Indenture effected by this Supplemental Indenture and agrees to execute the trusts created by the Indenture as hereby amended, but only upon the terms and conditions set forth in this Supplemental Indenture and the Indenture.  Without limiting the generality of the foregoing, the Trustee assumes no responsibility for the correctness of the recitals contained herein, which shall be taken as the statements of the Company and except as provided in the Indenture the Trustee shall not be responsible or accountable in any way whatsoever for or with respect to the validity or execution or sufficiency of this Supplemental Indenture or the Solicitation Documents and the Trustee makes no representation with respect thereto.  All rights,
protections, privileges, indemnities and benefits granted or afforded to the Trustee under the Indenture shall be deemed incorporated herein by this reference and shall be deemed applicable to all actions taken, suffered or omitted by the Trustee under this Supplemental Indenture.

 

 

	
             
 	
             
 	
             
 
	
             
 	
            4
 	
             
 

 

 

 

 

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Supplemental Indenture to be duly executed, and their respective corporate seals to be hereunto affixed and attested, all as of the day and year first above written.

THE INTERPUBLIC GROUP OF COMPANIES, INC.

 

 

	
      By: /s/ Ellen Johnson                                    
 

Name:    Ellen Johnson

	
            Title:  
 	
            Senior Vice President and Treasurer
 

 

Attest:

 

	/s/ Nicholas J. Camera                                      
	
            Name:
 	
            Nicholas J. Camera
 	
             

	
            Title:
 	
            Senior Vice President, General Counsel
 
	
             
	
            and Secretary
 	
             

				

 

SUNTRUST BANK 

as Trustee

	
      By: /s/ George T. Hogan                                         
 

Name:    George T. Hogan

	
            Title:  
 	
            Vice President
 

 

 

 

 

	
             
 	
             
 	
             
 
	
             
 	
            5Exhibit 10.15

                         OMINICORDER TECHNOLOGIES, INC.
                           125 Wilbur Place, Suite 120
                             Bohemia, New York 11716

                                                     February 17, 2005

Michael Anbar, Ph.D.
145 Deer Run Road
Amherst, New York  14221

             Amendment to Settlement Agreement Dated October 3, 2001

Dear Dr. Anbar:

         This letter is meant to reflect an Amendment to our Settlement
Agreement with you dated October 3, 2001. The additional terms are as follows:

         1. An up-front stock grant will be issued in your name or on your
behalf to a charitable foundation of 250,000 "restricted" shares of Common
Stock, par value $.001 per share, of OmniCorder (the "Restricted Stock"), which
shares may not be subsequently transferred for a period of two years and shall
be delivered by OmniCorder.

         2. Acquisition of Mental Stress Monitoring Technology Patent (United
States Patent 5,771,261). As part of the consideration under this agreement, you
hereby assign all of your right, title and interest in and to the confidential
know-how, technology and patent rights for the mental stress monitoring (the
"Patent Rights") invented, discovered and developed by you. You shall, without
additional consideration, cooperate fully with and assist OminiCorder in any and
all efforts necessary finalize the transfer of the patent, and any other
intellectual property associated with mental stress monitoring in your
possession. You agree to consult with the OmniCorder on the potential commercial
applications of this intellectual property without further compensation other
than the royalty below. The parties will also enter into a royalty agreement
providing you with a royalty of $300 per unit with regard to sales by OmniCorder
of systems that utilizes the Patent Rights. No royalties shall accrue on
disposition of reasonable quantities of such system for no charge as pilot,
sample or demonstration units.

         3. Stock and Investor Acknowledgements. Without infringing on your
rights regarding OmniCorder stock you currently own, you understand and
acknowledge that (i) the Restricted Stock and any other shares of Common Stock
of OmniCorder to be received from OmniCorder hereunder have not been registered
with or approved by the U.S. Securities and Exchange Commission ("SEC") or any
state securities commission or authority; (ii) any subsequent transfer of such
shares by you is restricted in accordance with the provisions contained in this
letter agreement, as well as the requirements of the SEC and applicable state
securities laws; (iii) a legend referencing such restrictions on

<PAGE>

transfer shall be affixed to the stock certificates evidencing your shares; (iv)
you are a sophisticated investor capable of evaluating the merits and risks of
accepting the grant of shares in exchange for your efforts and contributions;
(v) OmniCorder has made available to you all relevant information and the
ability to ask questions of OmniCorder regarding its shares, financial condition
and business propsects; and (vi) you have had the ability to obtain independent
advise and counsel from your legal or tax advisors prior to executing this
letter agreement concerning the grant of shares to you. Notwithstanding anything
to the contrary above, with respect to shares to be received from OmniCorder
hereunder, OmniCorder undertakes to use its best efforts to register such shares
with the SEC by the filing of a Form SB-2 or S-3, or such other method as its
most appropriate in the circumstances to enable you (or your designee) to sell
such shares.

         4. You represent and warrant to OmniCorder that, except for
OmniCorder's obligations pursuant to this letter agreement, there are no claims,
suits, obligations or liabilities of any kind whatsoever which you currently
have against OmniCorder or any of its Affliliates. You and OmniCorder reaffirm
the Settlement Agreement dated October 3, 2001 except the following: 1.
Consultant fees delineated in the Consulting Agreement supercede any fees in
this agreement. 2. With respect to Paragraph 9 of the Settlement Agreement,
OmniCorder waives the restriction on Anbar from working on commercial
applications of infrared imaging in the diagnosis and management of breast
cancer and diabetes solely in solely for the purpose of fulfilling his
responsibilities under this agreement. 3. The transfer of Restricted Stock and
Patent Rights under this agreement.

         If you are in agreement with the foregoing, please sign and return to
OmniCorder a copy of this agreement, which thereupon will become a binding
agreement between OmniCorder and you.

                                  OMINCORDER TECHNOLOGIES, INC.

                                  By:  /s/ Joseph F. Lisa
                                       -----------------------------------------
                                       Name: Joseph F. Lisa
                                       Title: Chairman of the Board

Agreed and accepted as of
the date first above written

/s/ Michael Anbar
----------------------------
Michael Anbar, Ph.D.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00082-of-00352.parquet"}]]